Article
GISAID’s Role in Pandemic Response
Registro en:
KHARE, Shruti et al. GISAID’s Role in Pandemic Response. China CDC Weekly, v. 3, n. 49, p. 1049-1051, Nov. 2021.
0254-6450
10.46234/ccdcw2021.255
Autor
Khare, Shruti
Gurry, Céline
Freitas, Lucas
Schultz, Mark B.
Bach, Gunter
Diallo, Amadou
Akite, Nancy
Ho, Joses
Lee, Raphael Tc
Yeo, Winston
Maurer-Stroh, Sebastian
Gisaid Core Curation Team
Resumen
GISAID is a global data science initiative and the
primary source of genomic and associated metadata of
all influenza viruses, Respiratory Syncytial Virus (RSV)
and severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), the pandemic coronavirus causing
coronavirus disease 2019 (COVID-19). GISAID’s
publicly accessible data sharing platform enables
collaboration of over 42,000 participating researchers
from 198 nations and data generators from over 3,500
institutions across the globe. Since the first wholegenome
sequences were made available by China CDC
through GISAID on January 10, 2020, over 5 million
genetic sequences of SARS-CoV-2 from 194 countries
and territories have been made publicly available
through GISAID’s EpiCoV database as of November
9, 2021. This high-quality, curated data enabled the
rapid development of diagnostic and prophylactic
measures against SARS-CoV-2 including the first
diagnostic tests and the first vaccines to combat
COVID-19 as well as continuous monitoring of
emerging variants in near real-time.